Rigel Pharmaceuticals
RIGL
47.69
-0.31
-0.64%
Rigel Pharmaceuticals
US · RIGL
#3318 by market cap
47.69
-0.31
-0.64%
Live - 5344 symbols - heartbeat 78s ago
· 2026-10-08 09:53
After-hours
47.00
-2.06%
- Market cap
- 890.75M
- P/E (TTM)i
- 2.82
- P/Bi
- 2.09
- EPSi
- 19.48
- Div yieldi
- 0.00%
- 52W posi
- 83%
Reader sentiment
Are you bullish or bearish on RIGL?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 4 analysts
Buy
Avg price target
65.00 +36.3%
Price target rangecurrent 47.69
Low43.00
Avg65.00
High85.00
Buy 50%
Hold 50%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-05 | H.C. Wainwright | -- | BUY | 85.00 |
| 2026-09-08 | H.C. Wainwright | -- | BUY | 85.00 |
| 2026-08-17 | Piper Sandler | -- | HOLD | 49.00 |
| 2026-08-14 | H.C. Wainwright | -- | BUY | 85.00 |
| 2026-08-06 | Citi | -- | BUY | 83.00 |
| 2026-08-05 | Citi | -- | BUY | 83.00 |
| 2026-08-05 | H.C. Wainwright | -- | BUY | 57.00 |
| 2026-08-04 | Cantor Fitzgerald | -- | HOLD | 43.00 |
| 2026-06-02 | H.C. Wainwright | -- | BUY | 57.00 |
| 2026-05-27 | H.C. Wainwright | -- | BUY | 57.00 |
| 2026-05-22 | H.C. Wainwright | -- | BUY | 57.00 |
| 2026-05-13 | Piper Sandler | -- | HOLD | 40.00 |
| 2026-05-13 | Citi | -- | BUY | 81.00 |
| 2026-05-12 | Citi | -- | BUY | 81.00 |
| 2026-05-12 | H.C. Wainwright | -- | BUY | 57.00 |
| 2026-05-07 | Piper Sandler | -- | HOLD | 40.00 |
| 2026-05-07 | Citi | -- | BUY | 69.00 |
| 2026-05-06 | H.C. Wainwright | -- | BUY | 57.00 |
| 2026-04-24 | Piper Sandler | -- | HOLD | 40.00 |
| 2026-04-22 | H.C. Wainwright | -- | BUY | 57.00 |
| 2026-03-31 | H.C. Wainwright | -- | BUY | 57.00 |
| 2026-03-04 | Citi | -- | BUY | 71.00 |
| 2026-03-04 | H.C. Wainwright | -- | BUY | 57.00 |
| 2026-03-03 | Cantor Fitzgerald | -- | HOLD | 38.00 |
| 2026-02-06 | Piper Sandler | -- | HOLD | 42.00 |
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-04 | After close | ±15.14% | +4.60% (in line) |
| 2026/Q1 | 2026-05-05 | After close | ±17.72% | -5.06% (in line) |
| 2025/Q4 | 2026-03-03 | After close | ±19.73% | -10.27% (in line) |
| 2025/Q3 | 2025-11-04 | After close | ±16.47% | +33.37% (beat) |
| 2025/Q2 | 2025-08-05 | After close | ±14.19% | +22.98% (beat) |
| 2025/Q1 | 2025-05-06 | After close | ±9.84% | +1.15% (in line) |
| 2024/Q4 | 2025-03-04 | After close | ±15.73% | -8.11% (in line) |
| 2024/Q3 | 2024-11-07 | After close | ±22.73% | +42.94% (beat) |
| 2024/Q2 | 2024-08-06 | After close | ±19.29% | +5.79% (in line) |
| 2024/Q1 | 2024-05-07 | After close | ±25.21% | -16.61% (in line) |
| 2023/Q4 | 2024-03-05 | After close | ±25.41% | +5.41% (in line) |
| 2023/Q3 | 2023-11-07 | After close | ±28.72% | +2.24% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 09:53:13 · For reference only, not investment advice and not tailored to your situation.